Stifel Financial Corp Insmed Inc Transaction History

Stifel Financial Corp

$93.7 Billion
Q4 2024

A detailed history of Stifel Financial Corp transactions in Insmed Inc stock. As of the latest transaction made, Stifel Financial Corp holds 26,880 shares of INSM stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,880

Previous 33,854 20.6%

Holding current value

$2.1 Million

Previous $2.47 Million 24.93%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$66.29 - $76.63 $462,306 - $534,417	-6,974 Reduced 20.6%	26,880 $1.86 Million
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $122,326 - $155,886	-1,973 Reduced 5.51%	33,854 $2.47 Million
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $513,480 - $1.63 Million	23,340 Added 186.91%	35,827 $2.4 Million
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $1,157 - $1,347	45 Added 0.36%	12,487 $338,000
Q4 2023 Feb 12, 2024	SELL	$23.42 - $31.74 $27,822 - $37,707	-1,188 Reduced 8.72%	12,442 $385,000
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $21,706 - $29,434	-1,093 Reduced 7.42%	13,630 $344,000
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $242,046 - $310,655	14,723 New	14,723 $310,000
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $4,312 - $5,880	254 Added 2.06%	12,608 $251,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $6,264 - $8,463	300 Added 2.49%	12,354 $266,000
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $6,981 - $10,515	409 Added 3.51%	12,054 $238,000
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $7,739 - $10,661	379 Added 3.36%	11,645 $274,000
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $144,517 - $186,717	-5,582 Reduced 33.13%	11,266 $307,000
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $11,544 - $15,147	-514 Reduced 2.96%	16,848 $464,000
Q2 2021 Aug 13, 2021	SELL	$24.17 - $36.01 $130,735 - $194,778	-5,409 Reduced 23.75%	17,362 $494,000
Q1 2021 May 14, 2021	BUY	$32.28 - $44.3 $207,560 - $284,849	6,430 Added 39.35%	22,771 $776,000
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $1,792 - $2,310	-57 Reduced 0.35%	16,341 $544,000
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $375,024 - $497,628	-14,424 Reduced 46.8%	16,398 $527,000
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $111,059 - $231,564	7,871 Added 34.29%	30,822 $849,000
Q1 2020 May 14, 2020	SELL	$13.63 - $33.98 $58,636 - $146,181	-4,302 Reduced 15.79%	22,951 $371,000
Q4 2019 Feb 13, 2020	BUY	$16.12 - $24.98 $6,673 - $10,341	414 Added 1.54%	27,253 $646,000
Q3 2019 Nov 19, 2019	BUY	$15.49 - $25.78 $5,421 - $9,023	350 Added 1.32%	26,839 $483,000
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $12,841 - $21,371	-829 Reduced 3.03%	26,489 $477,000
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $76,475 - $107,031	-3,325 Reduced 10.85%	27,318 $713,000
Q1 2019 May 14, 2019	SELL	$13.91 - $31.15 $33,467 - $74,946	-2,406 Reduced 7.28%	30,643 $900,000
Q4 2018 Feb 13, 2019	BUY	$11.6 - $18.7 $211,514 - $340,975	18,234 Added 123.08%	33,049 $434,000
Q3 2018 Nov 13, 2018	BUY	$18.95 - $28.08 $280,744 - $416,005	14,815 New	14,815 $296,000

Others Institutions Holding INSM

# of Institutions

497

Shares Held

189M

Call Options Held

3.21M

Put Options Held

2.72M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Insmed Inc Transaction History